Optimizing Care for Patients With Adverse Events From Immunotherapeutics.
Sheehan K, Price C, Hafez N. Optimizing Care for Patients With Adverse Events From Immunotherapeutics. The Cancer Journal 2020, 26: 537-542. PMID: 33298725, DOI: 10.1097/ppo.0000000000000492.BooksConceptsImmune checkpoint inhibitorsAdverse eventsCheckpoint inhibitorsImmune therapyGuideline-driven managementMajority of irAEsSteroid-refractory casesRisk patientsOptimal carePredictive biomarkersTumor boardIrAEsWellness clinicPatientsEarly detectionTranslational researchTherapyCareCommon occurrenceInhibitorsImmunotherapeuticsClinicSteroidsImmuneBiomarkers